» Authors » David J Moore

David J Moore

Explore the profile of David J Moore including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 411
Citations 7445
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Baim-Lance A, Cooley S, Yoo-Jeong M, Ances B, Duque G, Ellis R, et al.
J Gerontol A Biol Sci Med Sci . 2024 Nov; 80(1). PMID: 39492669
Integrating antiretroviral therapy into HIV care dramatically extended the lifespan for people living with HIV. Improving the health span requires understanding aging, HIV, associated comorbid conditions, and concurrent treatments. The...
12.
Zhao H, Kvitne K, Brungs C, Mohan S, Charron-Lamoureux V, Bittremieux W, et al.
bioRxiv . 2024 Oct; PMID: 39416075
Despite extensive efforts, extracting information on medication exposure from clinical records remains challenging. To complement this approach, we developed the tandem mass spectrometry (MS/MS) based GNPS Drug Library. This resource...
13.
Bender A, Moore D, Perkins M, Hunt R, Haardorfer R
AIDS Behav . 2024 Sep; 29(1):55-63. PMID: 39307896
The National Institutes of Health Toolbox Emotion Battery (NIHTB-EB) was developed to provide researchers and clinicians with a concise tool for measuring emotional health. The NIHTB-EB has been validated and...
14.
Levin J, Moore D, Briggs F, Rahman M, Montoya J, Depp C, et al.
Int J Psychiatry Med . 2024 Sep; 60(2):203-220. PMID: 39276142
Objective: Individuals with bipolar disorder (BD) have high rates of suboptimal medication adherence, medical illness, and premature mortality, largely from cardiovascular causes. This study examined the association between adherence to...
15.
Lane M, Moore D
Int J Cosmet Sci . 2024 Aug; 46(4):479-480. PMID: 39113307
No abstract available.
16.
Prescott M, Yeager S, Ham L, Rivera Saldana C, Serrano V, Narez J, et al.
JMIR AI . 2024 Aug; 3:e54482. PMID: 39094113
Background: Qualitative methods are incredibly beneficial to the dissemination and implementation of new digital health interventions; however, these methods can be time intensive and slow down dissemination when timely knowledge...
17.
Tang B, Ellis R, Vaida F, Umlauf A, Franklin D, Dastgheyb R, et al.
Brain Commun . 2024 Jul; 6(4):fcae224. PMID: 39077377
Neuropsychiatric complications such as neurocognitive impairment and depression are common in people with HIV despite viral suppression on antiretroviral therapy, but these conditions are heterogeneous in their clinical presentations and...
18.
Kale A, Dattani R, Tabansi A, Hogg H, Pearson R, Glocker B, et al.
JMIR Res Protoc . 2024 Jul; 13:e48156. PMID: 38990628
Background: The reporting of adverse events (AEs) relating to medical devices is a long-standing area of concern, with suboptimal reporting due to a range of factors including a failure to...
19.
Masters M, Campbell L, Yu J, Heaton A, Erlandson K, Garudadri H, et al.
AIDS Res Hum Retroviruses . 2024 Jul; 41(3):124-131. PMID: 38973466
As the number of older people with HIV (PWH) grows, accidental falls and their associated negative health outcomes are of increasing concern. Fall risk can be measured using novel screening...
20.
Kale A, Hogg H, Pearson R, Glocker B, Golder S, Coombe A, et al.
JMIR Res Protoc . 2024 Jun; 13:e51614. PMID: 38941147
Background: Artificial intelligence (AI) medical devices have the potential to transform existing clinical workflows and ultimately improve patient outcomes. AI medical devices have shown potential for a range of clinical...